X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA ORCHID PHARMA LTD NATCO PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x 30.7 -0.6 - View Chart
P/BV x 23.2 0.4 5,309.2% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 NATCO PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
ORCHID PHARMA LTD
Sep-13
NATCO PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs877194 452.1%   
Low Rs42435 1,210.0%   
Sales per share (Unadj.) Rs223.4276.5 80.8%  
Earnings per share (Unadj.) Rs31.1-79.2 -39.2%  
Cash flow per share (Unadj.) Rs40.3-43.5 -92.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs219.553.9 406.9%  
Shares outstanding (eoy) m33.0770.45 46.9%   
Bonus/Rights/Conversions PAESOP-  
Price / Sales ratio x2.90.4 702.7%   
Avg P/E ratio x20.9-1.4 -1,447.9%  
P/CF ratio (eoy) x16.1-2.6 -612.7%  
Price / Book Value ratio x3.02.1 139.6%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m21,5048,067 266.6%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m1,1282,527 44.6%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m7,38919,477 37.9%  
Other income Rs m167407 41.0%   
Total revenues Rs m7,55619,884 38.0%   
Gross profit Rs m1,7931,103 162.6%  
Depreciation Rs m3042,519 12.1%   
Interest Rs m3665,227 7.0%   
Profit before tax Rs m1,290-6,236 -20.7%   
Minority Interest Rs m4620 235.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m309-125 -246.6%   
Profit after tax Rs m1,027-5,580 -18.4%  
Gross profit margin %24.35.7 428.7%  
Effective tax rate %23.92.0 1,192.1%   
Net profit margin %13.9-28.7 -48.5%  
BALANCE SHEET DATA
Current assets Rs m3,68111,014 33.4%   
Current liabilities Rs m3,12332,060 9.7%   
Net working cap to sales %7.6-108.1 -7.0%  
Current ratio x1.20.3 343.1%  
Inventory Days Days8995 94.3%  
Debtors Days Days5934 174.9%  
Net fixed assets Rs m7,68529,440 26.1%   
Share capital Rs m331705 46.9%   
"Free" reserves Rs m6,6702,043 326.5%   
Net worth Rs m7,2593,800 191.0%   
Long term debt Rs m9559,018 10.6%   
Total assets Rs m11,95746,510 25.7%  
Interest coverage x4.5-0.2 -2,341.6%   
Debt to equity ratio x0.12.4 5.5%  
Sales to assets ratio x0.60.4 147.6%   
Return on assets %11.7-0.8 -1,533.5%  
Return on equity %14.2-146.9 -9.6%  
Return on capital %20.7-3.7 -554.9%  
Exports to sales %39.437.9 103.9%   
Imports to sales %5.722.6 25.2%   
Exports (fob) Rs m2,9087,378 39.4%   
Imports (cif) Rs m4214,406 9.6%   
Fx inflow Rs m3,4457,513 45.9%   
Fx outflow Rs m7035,649 12.4%   
Net fx Rs m2,7431,865 147.1%   
CASH FLOW
From Operations Rs m1,4401,682 85.6%  
From Investments Rs m-1,089-9,860 11.0%  
From Financial Activity Rs m-3536,644 -5.3%  
Net Cashflow Rs m-1-1,535 0.1%  

Share Holding

Indian Promoters % 52.0 32.3 161.1%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 4.6 170.4%  
FIIs % 16.6 3.3 503.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 26.0 55.3 47.0%  
Shareholders   25,395 84,811 29.9%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   SUVEN LIFE  SUN PHARMA  PFIZER  FDC LTD.  SHASUN PHARMA  

Compare NATCO PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 19, 2018 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 8-QTR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS